Rejuve.AI 的长寿生态系统通过加密货币的采用而增强

长寿研究平台 Rejuve.AI 宣布与 GlycanAge、Vita Authentica 和 Peptide Bioregulator 建立合作伙伴关系，使消费者能够使用 RJV 加密代币购买他们的产品。这些合作伙伴关系允许个人通过 Rejuve.AI 的长寿应用程序将其健康数据货币化，同时通过为新疗法和疗法的开发提供有价值的数据来为长寿研究做出贡献。

Rejuve.AI's Longevity Ecosystem Expands with Crypto Payment Adoption

Rejuve.AI 的长寿生态系统随着加密支付的采用而扩展

SINGULARITYNET'S HEALTHCARE FORAY GAINS MOMENTUM

SINGULARITYNET 的医疗保健进军势头强劲

San Francisco, California - Rejuve.AI, a pioneering longevity AI company operating within the SingularityNET ecosystem, has announced a groundbreaking partnership with three prominent consumer health brands: GlycanAge, Vita Authentica, and Peptide Bioregulator. This collaboration marks a transformative step towards democratizing longevity research and healthy aging through the integration of blockchain and AI.

加利福尼亚州旧金山 - Rejuve.AI 是一家在 SingularityNET 生态系统中运营的领先长寿人工智能公司，宣布与三个著名的消费者健康品牌建立突破性的合作伙伴关系：GlycanAge、Vita Authentica 和 Peptide Bioregulator。此次合作标志着通过区块链和人工智能的整合，朝着民主化长寿研究和健康老龄化迈出了变革性的一步。

The three partner brands will now accept Rejuve.AI's native cryptocurrency, RJV, as payment for their products and services. This move not only enhances the accessibility of personalized longevity solutions but also contributes significantly to the burgeoning longevity sector.

这三个合作品牌现在将接受 Rejuve.AI 的原生加密货币 RJV 作为其产品和服务的付款方式。此举不仅提高了个性化长寿解决方案的可及性，而且为蓬勃发展的长寿行业做出了重大贡献。

REJUVENATING LONGEVITY RESEARCH THROUGH DECENTRALIZATION

通过去中心化振兴长寿研究

Rejuve.AI's decentralized longevity research platform empowers individuals to share their medical, lifestyle, and biological data. Leveraging AI's transformative capabilities, the platform translates this vast data into actionable insights that guide personalized longevity strategies.

Rejuve.AI 的去中心化长寿研究平台使个人能够分享他们的医疗、生活方式和生物数据。该平台利用人工智能的变革能力，将大量数据转化为可操作的见解，指导个性化的长寿策略。

The Longevity App, developed by Rejuve.AI, provides a comprehensive platform for users to submit their health data from various sources, including surveys, lab results, and wearable devices. In return for sharing their valuable health information, users receive RJV tokens redeemable for products and services offered by Rejuve.AI's partner brands.

Longevity App 由 Rejuve.AI 开发，为用户提供了一个综合平台，可以从各种来源提交健康数据，包括调查、实验室结果和可穿戴设备。作为分享宝贵健康信息的回报，用户将获得 RJV 代币，可兑换 Rejuve.AI 合作伙伴品牌提供的产品和服务。

This data-sharing mechanism not only monetizes users' health data but also fuels the advancement of longevity research. The data collected through the Longevity App contributes to the development of new drugs, therapies, and treatments, ultimately benefiting humanity's pursuit of healthier and longer lives.

这种数据共享机制不仅可以将用户的健康数据货币化，还可以推动长寿研究的进步。通过长寿应用程序收集的数据有助于新药、疗法和疗法的开发，最终有利于人类追求更健康、更长寿的生活。

REJUVENATING TREATMENT DEVELOPMENT THROUGH BIOLOGICAL INSIGHTS

通过生物学见解进行复兴疗法的开发

Rejuve.Bio, a fellow SingularityNET company, capitalizes on the insights generated by Rejuve.AI to develop and commercialize innovative experimental therapies. The partnership with consumer health brands like GlycanAge, Vita Authentica, and Peptide Bioregulator further strengthens Rejuve.Bio's efforts to bring transformative longevity solutions to market.

Rejuve.Bio 是 SingularityNET 旗下的一家公司，它利用 Rejuve.AI 产生的见解来开发创新的实验疗法并将其商业化。与 GlycanAge、Vita Authentica 和 Peptide Bioregulator 等消费者健康品牌的合作进一步加强了 Rejuve.Bio 将变革性长寿解决方案推向市场的努力。

EMBRACING THE VALUE OF LONGEVITY RESEARCH

拥抱长寿研究的价值

The decision by GlycanAge, Vita Authentica, and Peptide Bioregulator to accept RJV tokens reflects their unwavering belief in the transformative power of longevity research.

GlycanAge、Vita Authentica 和 Peptide Bioregulator 接受 RJV 代币的决定反映了他们对长寿研究的变革力量的坚定信念。

"We are thrilled to see the industry recognizing the crucial role that crypto plays in healthcare and longevity research," said Jasmine Smith, CEO of Rejuve.AI. "Our partnership with these leading brands demonstrates our commitment to realizing our mission of pioneering groundbreaking longevity research and innovation."

Rejuve.AI 首席执行官 Jasmine Smith 表示：“我们很高兴看到业界认识到加密货币在医疗保健和长寿研究中发挥的关键作用。” “我们与这些领先品牌的合作表明我们致力于实现开创性的长寿研究和创新的使命。”

CONCLUSION

结论

The integration of RJV crypto tokens into the offerings of GlycanAge, Vita Authentica, and Peptide Bioregulator marks a significant milestone in the advancement of longevity research. This collaboration opens new avenues for funding, incentivizing data sharing, and fostering innovation within the longevity sector. As the adoption of RJV tokens expands, Rejuve.AI and its partners continue to reshape the future of healthy aging, empowering individuals and researchers alike to unlock the potential of a longer, healthier life.

将 RJV 加密代币集成到 GlycanAge、Vita Authentica 和 Peptide Bioregulator 的产品中，标志着长寿研究进展的一个重要里程碑。此次合作开辟了新的融资途径，激励数据共享，并促进长寿领域的创新。随着 RJV 代币的采用范围扩大，Rejuve.AI 及其合作伙伴继续重塑健康老龄化的未来，使个人和研究人员能够释放更长寿、更健康生活的潜力。